Advanced haemodynamic monitoring employing minimally invasive cardiac output measurement may lead to significant improvements in patient outcomes in major surgery. However, the precision (scatter) of measurement of available generic technologies has been shown to be unsatisfactory with percentage error of agreement with bolus thermodilution (% error) of 40% to 50%. Simultaneous measurement and averaging by two or more technologies may reduce random measurement scatter and improve precision. This concept, called the hybrid method, was tested by comparing accuracy and precision of measurement relative to bolus thermodilution using combinations of three component methods. Thirty patients scheduled for either elective cardiac surgery or liver transplantation were studied. Agreement with simultaneous bolus thermodilution of hybrid combinations of continuous thermodilution (Qt CCO ) or Vigeleo TM /FloTrac TM pulse contour measurement (Qt FT ) with pulmonary Capnotracking (Qt CO2 ) was assessed pre-and post-cardiopulmonary bypass or pre-and post-reperfusion of the donor liver and compared with that of the component methods alone. Hybridisation of Qt CO2 (% error 42.2) and Qt CCO (% error 51.3) achieved significantly better precision (% error 31.3) than the component methods (P=0.0004) and (P=0.0195). Due to poor inherent precision of Qt FT (% error 82.8), hybrid combination of Qt FT with Qt CO2 did not result in better precision than Qt CO2 alone. Hybrid measurement can approach a 30% error, which is recommended as the upper limit for acceptability. This is a practical option where at least one component method, such as Capnotracking, is automated and does not increase the cost or complexity of the measurement process.
The use of advanced haemodynamic monitoring, employing minimally invasive cardiac output measurement may lead to significantly improved patient outcomes in major surgery 1 . Refinements in circulatory management and fluid maintenance and resuscitation strategies are possible where fluid responsiveness is measured after fluid administration or other manoeuvres such as passive leg-raising, using one of a variety of available minimally invasive technologies for monitoring changes in cardiac output 2, 3 .
However, the reliability of measurement by these technologies has been shown to be unsatisfactory 4 . The accuracy and precision of a method being tested are assessed by comparison with paired measurements made by an accepted reference method. The mean difference between the test and reference methods is the mean bias, and the standard deviation (SD) of the difference is the precision. The limits of agreement are defined as two SDs either side of the mean bias, within which 95% of measurements are expected to lie. Percentage error is defined as two SDs of the difference divided by the mean. In a meta-analysis of data from a ten-year review of publications, the precision of measurement of available generic technologies (pulse contour method, oesophageal Doppler, partial carbon dioxide rebreathing and transthoracic electrical bioimpedance) was found to be well outside the widely quoted criterion for acceptability of agreement with bolus thermodilution, which equates to a percentage error of 30% 5 . The percentage error for these technologies ranged from approximately 40% to 50% 4, 6 .
The overall precision of measurement for a given technology consists of both intra-patient and inter-patient variability and, in a large sample of patients, represents random scatter of measurement around the mean bias for the method. Simultaneous measurement and averaging by two or more 'component' technologies may reduce this scatter and result in narrower limits of agreement with a reference method and better precision. This might be a practical concept where one of the component methods is noninvasive, automatic and low-cost, this not adding to the overall complexity of the measurement for the clinician.
This concept (referred to here as the hybrid method) and its limitations were tested by theoretical modelling and by clinical testing in patients undergoing major surgery, using measurement of cardiac output by bolus thermodilution (Qt TD ) as the reference method. Comparison was made against simultaneous measurements by an invasive established method in the form of continuous thermodilution (Qt CCO ), as well as a newer, minimally invasive alternative, the Vigeleo™/FloTrac™ pulse contour method (Qt FT ). The agreement with Qt TD of these two methods was compared to that of hybrid combinations of them with a method based on lung carbon dioxide elimination in ventilated patients (Capnotrack™ [Qt CO2 ]). This was chosen because Qt CO2 , an approach developed and validated by the author 7 , is a fully automated measurement technique that can potentially be combined with other more invasive component methods without significantly increasing the cost, work or complexity of obtaining a hybrid measurement of cardiac output with potentially improved accuracy and precision.
MATERIALS AND METHODS

Computer modelling
A simple model of random scatter in measurement of cardiac output (Qt) was constructed, using a Gaussian white noise generator, with a defined SD around a given mean value, which was set at 5 l/minute. The percentage error was set at 40% either side of the mean, with SD of 1.02 l/minute. Ninety-five percent of all generated values were incorporated in 1.96 SD. Two independent white noise generators, A and B, were run using these inputs, each generating 10 6 values, representing measurements by two independent 'component' methods for Qt measurement, Qt A and Qt B . These measurement pairs were averaged to produce 10 6 hybrid values Qt H , according to:
where Qt H is the simulated Qt calculated by the hybrid method, and Qt A and Qt B simulate the Qt measured by component methods A and B.
The SD of the resulting distribution of Qt H was calculated. The effect on the SD of Qt H produced by varying the SD of Qt B relative to that of Qt A was also examined. The model was constructed using LabVIEW™ 2009 (National Instruments, Austin, TX, USA).
Clinical study
With approval by the local institutional human research ethics committee (Austin Health HREC Project No. 03432, 11/1/2008), 30 adult patients scheduled for either elective cardiac surgery or orthotopic liver transplantation were approached and informed written consent was obtained for recruitment to the study. Patients who had a clinical history of severely impaired lung function (forced expiratory volume in one second/forced vital capacity <30% of predicted) were excluded from recruitment. Three 'component' methods for Qt measurement were used, pulmonary Qt CO2 , Qt CCO and Qt FT . Their measurements and those of their hybrid combinations (Qt CO2/CCO and QT CO2/FT ) were compared with simultaneous bolus right heart thermodilution measurements (Qt TD ) as follows.
Routine anaesthetic management and monitoring was undertaken, including insertion of an indwelling 18 or 20 gauge radial artery catheter with a FloTrac™ transducer attached to a Vigeleo™ EV1000 monitor (Edwards Lifesciences, Irvine, CA, USA), and a Vigilance™ pulmonary artery catheter attached to a Vigilance™ II monitor (Edwards Lifesciences, Irvine, CA, USA). The Vigeleo™ EV1000 is a pulse contour device that estimates stroke volume and cardiac output from the pulse pressure waveform according to a proprietary algorithm incorporating patient height, weight, sex and age, without the requirement for a calibration manoeuvre, using the manufacturer's third generation software. The Vigilance™ pulmonary artery catheter is capable of both Qt CCO and Qt TD measurement.
After relaxant general anaesthesia was induced and following endotracheal intubation, anaesthesia was maintained with inspired isoflurane or sevoflurane, titrated according to clinical indication and bispectral index, and a neuromuscular blocker. The endotracheal tube was attached via a breathing filter to a circle absorber system attached to an Aestiva ® anaesthetic machine (Datex-Ohmeda, GE Healthcare, Madison, WI, USA). The patient was ventilated with oxygen/ air by an Ohmeda 7800 anaesthesia ventilator at a minute ventilation adjusted to achieve an end-tidal CO 2 partial pressure of approximately 25 to 35 mmHg. Continuous automated measurement of Qt CO2 was done as follows 7 . A Fleisch pneumotachograph (Hans Rudolph Inc., KA, USA) and gas sampling port for breath-by-breath measurement of carbon dioxide elimination by the lungs (V CO2 ) were attached to the breathing system just proximal to the breathing filter. Tidal gas flow from the pneumotachograph and gas concentration data were downloaded to a personal computer (MacBook Pro ® , Apple Corp., Cupertino, CA, USA) via an analog-digital converter (USB 6009, National Instruments, Austin, TX, USA) for breathby-breath V CO2 and end-tidal CO 2 partial pressure measurement. The computer algorithm automatically modulated respiratory rate and inspiratory to expiratory ratio delivered by the ventilator for the initial calibration manoeuvre 7, 8 , after which continuous measurement of pulmonary blood-flow was made non-invasively from V CO2 measurement as described previously 7 . The initial calibration manoeuvre of Qt CO2 employs the differential Fick principle applied to CO 2 elimination (which is also used by devices employing the partial CO 2 rebreathing method) 9, 10 .
The measurement process was commenced after the patient's blood pressure and ventilatory status had been stabilised. For the current study, this was 15 to 30 minutes after induction of anaesthesia. Continuous measurements of Qt were then collected by Qt CO2 , Qt CCO and Qt FT . A simultaneous reference measurement of Qt was made by Qt TD using the Vigilance™ pulmonary artery catheter, by taking an average of five consecutive measurements using room temperature saline. The Qt CCO measurement delivered by the Vigilance™ monitor represented data over a three-minute average of continuous thermodilution prior to the bolus thermodilution measurement being done. Qt FT and Qt CO2 were simultaneous threeminute averages of data from the Vigeleo™ monitor and Capnotracking program, respectively. This data collection process was done once during the precardiopulmonary bypass period in patients undergoing cardiac surgery, and once prior to the anhepatic phase in patients undergoing liver transplantation. Where logistic and time constraints permitted, the measurement process was repeated approximately 30 minutes after separation from cardiopulmonary bypass and re-establishment of stable circulation in the cardiac surgery group, and after reperfusion of the donor organ in the liver transplant group. If there was ongoing cardiovascular instability, due to blood loss for instance, commencement was delayed until this was stabilised. For each set of measurements, the cardiac output calculated by the two hybrid combinations of interest (Qt CO2/CCO and Qt CO2/FT ) was determined from Equation 1.
Statistics
The accuracy and precision of measurement by each of the component methods and their hybrid combinations relative to Qt TD was assessed using the method of Bland and Altman, by calculation of the mean difference (bias) and precision (one SD of the difference) between measurements made by each method and Qt TD 11 . The upper and lower limits of agreement and the percentage error were determined as outlined above. The intraclass correlation coefficient was calculated as described by Norman and Streiner 12 . These calculations were done for each component method of measurement individually (Qt CO2 , Qt CCO and Qt FT ) and for Qt CO2/CCO and Qt CO2/FT .
The hypothesis tested was that a significant improvement in precision of agreement with Qt TD for Qt CCO and Qt FT could be achieved by hybrid combination of each of these with Qt CO2 . The primary endpoint was the difference in precision (using the calculated variance) of agreement with Qt TD between the invasive method Qt CCO and Qt CO2/CCO . The precision of agreement with Qt TD of the minimally invasive method Qt FT and Qt CO2/FT were similarly compared as a secondary endpoint.
The statistical significance of differences in variance of agreement with Qt TD was determined using either the F-test for normally distributed data or by Levene's robust test for equality of variances, which does not assume normality of data distributions 13 . For the purposes of the comparison of variance tests, preand post-cardiopulmonary bypass measurement and pre-and post-graft reperfusion measurements were treated as independent data-points. Statistical analysis was done using STATA 12 (StataCorp, College Station, TX, USA). The threshold of significance for each comparison was P=0.05.
RESULTS
Modelling
Raw data plots are shown in Figure 1 for the Gaussian white noise distributions for Qt A and Qt B and the resulting distribution of Qt H from Equation 1. The percentage errors for Qt A and Qt B were each set at 40%, and the resulting percentage error of Qt H was 28.3% or precisely 40/√2. Figure 5 : The percentage error in agreement with bolus thermodilution (% error) of four generic technologies for minimally invasive cardiac output measurement (PC, OD, PCRB and TEB) from published meta-analysis data 4 . The expected percentage error for each hybrid combination of these technologies, calculated using Equation 4 (Appendix). PC=pulse contour, OD=oesophageal Doppler, PCRB=partial carbon dioxide rebreathing, TEB=transthoracic electrical bioimpedance. Figure 2 shows the effect on the SD of hybrid measurement Qt H where the precision of Qt A and Qt B are not the same. As the SD of Qt B relative to that of Qt A is increased (from an equal value to an SD twice that of the Qt A ), the precision of Qt H remains better than that of Qt A until the SD of Qt H is approximately 1.75 times that of Qt A .
Clinical study
Thirteen male and 17 female patients participated in the study, with a mean height 166 cm (median 167, range 146 to 184 cm), mean weight 82 kg (median 74, range 56 to 133 kg) and mean age 61 years (median 61, range 37 to 85 years). Of these, 17 patients were undergoing cardiac surgery and 13 were undergoing liver transplantation. A second measurement was collected in 20 of the participants, giving a total of 50 measurements. The mean Qt TD was 5.9 l/minute, median 4.7 l/minute (range 2.0 to 14.9 l/minute). Figure 3 shows Bland-Altman plots of agreement between each method or hybrid combination and Qt TD . Bias, precision, percentage error data and intraclass correlation coefficient for each component method and for the primary hybrid combinations are summarised in Figure 4 . The arrows indicate the comparisons of variances made between each component method and its hybrid combinations, with the P value.
The bias relative to Qt TD was negligible for all methods. For Qt CO2 the precision of agreement with Qt TD and percentage error were 1.3 l/minute and 42.2%, respectively, similar to results in our previous study in a similar patient group 7 . The precision and percentage errors for Qt CCO were 1.5 l/minute and 51.3%, consistent with data published by Botero et al in a cardiac surgery group 14 . The precision and percentage errors of Qt FT (2.5 l/minute and 82.8%) were considerably wider than the other methods and wider than results found in a meta-analysis of published studies comparing this device with bolus thermodilution 4, 6 .
Qt CO2/CCO achieved a significantly better precision of agreement with Qt TD compared to Qt CCO alone (P=0.0004), with a percentage error relative to Qt TD of 31.3%. Qt CO2/FT also achieved significantly better precision of agreement than Qt FT alone (P=0.0095), with a percentage error relative to Qt TD of 47.5%. The precision of Qt CO2/CCO was also significantly better than that of Qt CO2 alone (P=0.0195 with Bonferroni correction for multiple comparisons), but the precision of Qt CO2/FT was not different to that of Qt CO2 alone. These comparisons are shown in Figure 4 . The precision of agreement with Qt TD of the other possible hybrid combination, that of Qt CCO and Qt FT (Qt CCO/FT ), had precision of 1.9 l/minute, percentage error 61.3%, intraclass correlation coefficient 0.80, and was not significantly better than that of either Qt CCO (P=0.2653) or Qt FT (P=0.0996) alone.
DISCUSSION
The current study demonstrates that substantial improvement in the precision of measurement of Qt can be obtained by the hybrid method, combining measurement by two methods. This may allow currently available technologies to approach or achieve the widely quoted criterion for acceptability of agreement with bolus thermodilution of percentage error equal to or less than 30% 5 .
Where two methods with equal precision of measurement are combined, the SD of difference relative to the reference Qt method (and by implication the true Qt) is reduced by a factor approximating 1/√2. This is outlined in the Appendix and shown by the modelling data in Figure 1 . Adding further methods to the model decreases the SD of the hybrid measurement but with diminishing returns for the increased complexity of the overall system if applied clinically, and this analysis was not made in our clinical study.
Using multiple technologies simultaneously increases both cost and complexity and is unlikely to be practical for two methods which are invasive, or which are labour-intensive and operator-dependent. However, where one or both of the methods are minimally or non-invasive and simple to use, or preferably automated, hybrid measurement can be a practical alternative. The Capnotracking method was chosen here because, unlike other minimally invasive alternatives, it is automated and hands-free, and can potentially be implemented as a fully integrated part of modern anaesthesia platforms, using only existing monitoring hardware (capnography and flow measurement) at low cost 7 . Combination of Capnotracking with a second method is not significantly more complex to implement than the second method alone, but with substantially improved precision of measurement.
A limitation in the current study is that an assessment of the ability of the hybrid method to improve the tracking of changes in Qt within a patient was not done because repeated measurements were not made in all patients. The data in the present study also demonstrate some limitations of the concept itself. Hybridisation will not usefully improve precision of measurement where one method has substantially worse precision than the other. In our clinical series, the precision of hybrid combinations of the Vigeleo™/ FloTrac™ with Capnotracking was not better than the precision of Capnotracking alone (Figure 4) . The same was found for hybrid combination with continuous thermodilution. This is consistent with the predictions of the modelling data in Figure 2 , and was due to the wide percentage error of Qt FT in this study.
The reduction in SD and percentage error from hybridisation assumes a normal distribution of differences compared to the reference method and is based on the stochastic nature of random scatter. Where correlation exists between the two hybridised component methods due to factors other than the Qt itself, the improvement in precision obtained from measurement averaging will be less than this. This is illustrated by the theoretical case where two methods are combined employing the same principles of measurement. Identical or nearly identical measurements will not be significantly modified by averaging. In fact, the ideal combination involves two or more methods of cardiac output measurement based on completely different physical and physiological principles, where artificial linkage of measurement due to factors such as mathematical coupling is not possible 15 . The meta-analysis published by Peyton and Chong showed that none of the four generic technologies for Qt measurement reviewed (pulse contour method, oesophageal Doppler, partial carbon dioxide rebreathing and transthoracic electrical bioimpedance) were significantly superior in precision of agreement with bolus thermodilution to the others, suggesting that combinations of these entirely different technologies are optimal for the hybrid method 4 .
The improved precision of measurement in the current study, achieved with hybrid combination of Capnotracking and continuous thermodilution, can also be expected from other technologies with comparable accuracy and precision. An estimate of the improvement in percentage error that can be expected from hybrid combinations of the currently available generic technologies can be made from published meta-analysis data, which found percentage errors in agreement with bolus thermodilution ranging from approximately 40% to 45% 4 . Figure 5 shows the expected percentage error for each hybrid combination of these technologies, using Equation 4 (Appendix). All combinations approach or exceed the 30% threshold that has been recommended by Critchley and Critchley as the criterion for acceptability of agreement with bolus thermodilution 5 . This threshold was based on the assumption of a percentage error of bolus thermodilution of 20% relative to the true cardiac output, which has been questioned, particularly in the presence of unstable haemodynamics [16] [17] [18] [19] [20] . Regardless of the real precision of bolus thermodilution as a reference method, our data suggest that hybridisation of measurements can achieve the desired precision of agreement across a wide range of haemodynamics under clinical conditions.
There has been a dramatic increase in interest over recent years in the potential for advanced haemodynamic monitoring to influence perioperative management and improve patient outcomes, particularly in major abdominal surgery 1, 3 . This has been driven in large part by the introduction of a variety of technologies for stroke volume and cardiac output measurement. However, realisation of this potential will be inhibited by unsatisfactory reliability of measurement 18 . Poor precision, representing random error of measurement, is a major contributor to this and a factor that limits the increased adoption of advanced haemodynamic monitoring in routine practice 4, 18 .
The challenge to achieve satisfactory reliability of measurement of Qt in the perioperative setting may be met by adoption of the hybrid method, which delivers substantially better precision of measurement where the component methods have intrinsic precision similar to that found in our recent meta-analysis. The hybrid method can be a practical clinical alternative where one or both of the component methods chosen are minimally invasive, automated and low-cost.
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If Method A and Method B have standard deviations of measurement SDA and SDB respectively, where a i and b i are simultaneous measurements made at time i and a and b are the means of N measurements by each method.
If H is the hybrid of measurements made by Methods A and B then
Combining with equations 2a and 2b
The fractional term on the right approximates zero in a large series, so that Where SD A and SD B are equal 
